These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 838019)

  • 1. Production and removal of 5-hydroxyindole acetic acid in the spinal region of the rabbit.
    Davidson DL; Glen AI
    Exp Neurol; 1977 Feb; 54(2):291-302. PubMed ID: 838019
    [No Abstract]   [Full Text] [Related]  

  • 2. The active transport of 5-hydroxyindol-3-ylacetic acid and 3-methoxy-4-hydroxyphenylacetic acid from a recirculatory perfusion system of the cerebral ventricles of the unanaesthetized dog.
    Ashcroft GW; Dow RC; Moir AT
    J Physiol; 1968 Dec; 199(2):397-425. PubMed ID: 5723518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of amine metabolites from the cerebrospinal fluid: the brain as a "sink".
    Wolfson LI; Katzman R; Escriva A
    Neurology; 1974 Aug; 24(8):772-9. PubMed ID: 4858421
    [No Abstract]   [Full Text] [Related]  

  • 4. Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.
    Guldberg HC; Ashcroft GW; Crawford TB
    Life Sci; 1966 Sep; 5(17):1571-5. PubMed ID: 5970680
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-hydroxyindoleacetic acid in the brain and cerebrospinal fluid of the rabbit following administration of drugs affecting 5-hydroxytryptamine.
    Bowers MB
    J Neurochem; 1970 Jun; 17(6):827-8. PubMed ID: 5426662
    [No Abstract]   [Full Text] [Related]  

  • 6. Exchange of 5-hydroxyindoleacetic acid between the spinal cord and lumbar cerebrospinal fluid.
    Bulat M; Zivković B
    J Physiol; 1978 Feb; 275():191-7. PubMed ID: 633105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid and brain of different rabbit breeds after treatment with probenecid.
    Andersson H; Roos BE
    J Pharm Pharmacol; 1972 Feb; 24(2):165-6. PubMed ID: 4401976
    [No Abstract]   [Full Text] [Related]  

  • 8. Transport mechanisms in the cerebrospinal fluid system for removal of acid metabolites from developing brain.
    Bass NH; Lundborg P
    Adv Exp Med Biol; 1976; 69():31-40. PubMed ID: 941740
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of probenecid on 5-hydroxyindoleacetic acid in cisternal cerebrospinal fluid of rats with portacaval anastomosis.
    Bergeron M; Swain MS; Molina-Holgado E; Reader TA; Butterworth RF
    Neurochem Res; 1995 Aug; 20(8):963-7. PubMed ID: 8587655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of probenecid on the elimination from CSF of intraventricularly injected 5-hydroxyindolecetic acid in normal and hydrocephalic dogs.
    Anderson H; Roos BE
    J Pharm Pharmacol; 1968 Nov; 20(11):879-81. PubMed ID: 4387498
    [No Abstract]   [Full Text] [Related]  

  • 11. Probenecid-induced accumulation of cyclic nucleotides, 5-hydroxyindoleacetic acid, and homovanillic acid in cisternal spinal fluid of genetically nervous dogs.
    Angel C; Deluca DC; Murphree OD
    Biol Psychiatry; 1976 Dec; 11(6):743-53. PubMed ID: 187258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of 5-hydroxyindoleacetic acid transport from the spinal fluid by probenecid.
    Zivković B; Bulat M
    J Pharm Pharmacol; 1971 Jul; 23(7):539-40. PubMed ID: 4397456
    [No Abstract]   [Full Text] [Related]  

  • 13. A.E. Bennett Award Paper. A kinetic analysis of 5-hydroxyindoleacetic acid excretion from rat brain and csf.
    Burns D; London J; Brunswick DJ; Pring M; Garfinkel D; Rabinowitz JL; Mendels J
    Biol Psychiatry; 1976 Apr; 11(2):125-57. PubMed ID: 971444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of a non-ionic contrast agent from cerebrospinal fluid to blood.
    Golman K; Wiik I; Salvesen S
    Neuroradiology; 1979 Dec; 18(5):227-33. PubMed ID: 583177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxyindoleacetic acid, homovanillic acid and tryptophan levels in CSF above and below a complete block of CSF flow.
    Young SN; Lal S; Martin JB; Ford RM; Sourkes TL
    Psychiatr Neurol Neurochir; 1973; 76(6):439-44. PubMed ID: 4781523
    [No Abstract]   [Full Text] [Related]  

  • 16. On the elimination of 5-hydroxyindoleacetic acid and homovanillic acid from cerebrospinal fluid.
    Andersson H; von Essen C; Roos BE
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):129-38. PubMed ID: 4741033
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
    Garelis E; Young SN; Lal S; Sourkes TL
    Brain Res; 1974 Oct; 79(1):1-8. PubMed ID: 4279131
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of probenecid on cerebral and cisternal cerebrospinal fluid lactate content.
    MacMillan V
    J Cereb Blood Flow Metab; 1987 Feb; 7(1):118-23. PubMed ID: 2433297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The elimination of 5-hydroxyindoleacetic acid from cerebrospinal fluid: characteristics of the acid transport system of the choroid plexus.
    Sampath SS; Neff NH
    J Pharmacol Exp Ther; 1974 Feb; 188(2):410-4. PubMed ID: 4359553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.